The short version of freeze-thaw cycle fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-12-12 and is reviewed periodically as new material appears.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic small-molecule REV-ERB agonist | Not a hormone or natural product |
| Primary targets | REV-ERBα and REV-ERBβ | Nuclear receptors involved in circadian and metabolic regulation |
| Appearance | White to off-white solid | Typical for purified research samples |
| Solubility | Soluble in DMSO and ethanol; low water solubility | Laboratory solubility depends on solvent and purity |
| Common synonyms | SR9009; Stenabolic | Stenabolic is a colloquial name, not a formal chemical name |
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Most pesticides protect crops against insects and plants, but in some cases antimicrobial pesticides are used to protect against various microorganisms such as bacteria, viruses, fungi, algae, and protozoa. The overuse of many pesticides in an effort to have a higher yield of crops has resulted in many of these microbes evolving a tolerance against these antimicrobial agents. Currently there are over 4000 antimicrobial pesticides registered with the US Environmental Protection Agency (EPA) and sold to market, showing the widespread use of these agents. It is estimated that for every single meal a person consumes, 0.3 g of pesticides is used, as 90% of all pesticide use is in agriculture. A majority of these products are used to help defend against the spread of infectious diseases, and hopefully protect public health. But out of the large amount of pesticides used, it is also estimated that less than 0.1% of those antimicrobial agents, actually reach their targets. That leaves over 99% of all pesticides used available to contaminate other resources. In soil, air, and water these antimicrobial agents are able to spread, coming in contact with more microorganisms and leading to these microbes evolving mechanisms to tolerate and further resist pesticides. The use of antifungal azole pesticides that drive environmental azole resistance have been linked to azole resistance cases in the clinical setting. The same issues confront the novel antifungal classes (e.g. orotomides) which are again being used in both the clinic and agriculture.
=== In medicine === Many hospitals have pneumatic tube systems which send samples to laboratories. Blood preservations are transported, where weight and transport duration matter as well as preventing haemolysis caused by centrifugal and accelerating forces. Pneumatic tube systems are also used in hospitals to transport X-rays, patient documents, general documents, drugs and test results. 6-inch (152 mm) pneumatic tube systems have been shown to handle heavy liter-capacity IV bags with significantly fewer jams compared to the 4-inch (102 mm) systems.
=== Classification === Historical classification systems were based on clinical factors. Until the early 1970s, the idea of a single amyloid substance predominated. Various descriptive classification systems were proposed based on the organ distribution of amyloid deposits and clinical findings. Most classification systems included primary (i.e., idiopathic) amyloidosis, in which no associated clinical condition was identified, and secondary amyloidosis (i.e., secondary to chronic inflammatory conditions). Some classification systems included myeloma-associated, familial, and localized amyloidosis. The modern era of amyloidosis classification began in the late 1960s with the development of methods to make amyloid fibrils soluble. These methods permitted scientists to study the chemical properties of amyloids. Descriptive terms such as primary amyloidosis, secondary amyloidosis, and others (e.g., senile amyloidosis), which are not based on cause, provide little useful information and are no longer recommended. The modern classification of amyloid disease tends to use an abbreviation of the protein that makes the majority of deposits, prefixed with the letter A. For example, amyloidosis caused by transthyretin is termed "ATTR". Deposition patterns vary between people but are almost always composed of just one amyloidogenic protein. Deposition can be systemic (affecting many different organ systems) or organ-specific. Many amyloidoses are inherited, due to mutations in the precursor protein.
== Structure == Lumican is a proteoglycan Class II member of the small leucine-rich proteoglycan (SLRP) family that includes decorin, biglycan, fibromodulin, keratocan, epiphycan, and osteoglycin. Like the other SLRPs, lumican has a molecular weight of about 40 kilodaltons and has four major intramolecular domains:
Smithsonian Institution Press, Washington and London. Monteiro A. (ed.) (2007). The Cone Collector 1: 1-28. Nelson, Laura (24 June 2004). "One slip, and you're dead..." Nature. 429 (6994): 798–799. doi:10.1038/429798a. Peters H, O'Leary BC, Hawkins JP, Carpenter KE, Roberts CM (2013). "Conus: first comprehensive conservation red list assessment of a marine gastropod mollusc genus". PLOS ONE. 8 (12) e83353. Bibcode:2013PLoSO...883353P. doi:10.1371/journal.pone.0083353. PMC 3871662. PMID 24376693. Petuch EJ (1986). "New South American gastropods in the genera Conus (Conidae) and Latirus (Fasciolariidae)". Proceedings of the Biological Society of Washington. 99: 8–14. Petuch, E. J. 1987. New Caribbean molluscan faunas. [v] + 154 + A1-A4, 29 pls. Coastal Education & Research Foundation: Charlottesville, Virginia Petuch, E. J. 1988. Neogene history of tropical American mollusks. [vi] + 217, 39 pls. Coastal Education & Research Foundation: Charlottesville, Virginia Petuch EJ (1990). "A new molluscan faunule from the Caribbean coast of Panama". Nautilus. 104: 57–70. Petuch EJ (1992). "Molluscan discoveries from the tropical Western Atlantic region. Part II. New species of Conus from the Bahamas Platform, Central American and northern South American coasts, and the Lesser Antilles". La Conchiglia. 24 (265): 10–15. Petuch EJ (2000). "A review of the conid subgenus Purpuriconus da Motta, 1991, with the descriptions of two new Bahamian species". Ruthenica: Russian Malacological Journal. 10: 81–87. Petuch EJ (2004). Cenozoic Seas. Boca Raton: CRC Press.
Sources: en.wikipedia.org
These decrees were described by historian Paul Ginsborg as “the only attempt made by leftist government officials to advance on the path of reform”. Gullo, who became “Minister of the Peasants”, achieved two important results: the southern peasants' became aware of the state's support and the laborers' realization that uniting in cooperatives brought them power. Thanks in part to cooperation with trade unions, especially Giuseppe Di Vittorio's Italian General Confederation of Labour, Gullo's reform efforts were extended with two other decrees. One modified the taxable labor rate. Trade unions were empowered to dictate the number of laborers on a landowner's farmland. The latter allowed trade unionists to manage the labor placements according to seniority. With these measures they prevented war and brought the union onto the side of the peasants. The Gullo decrees were opposed by the agrarians, using the organized underworld and by enlisting the support the more conservative of the Christian Democrats (CD), who were against the revolutionary government measures. Local Christian Democrats were often involved with the past regime. They succeeded in amending the decrees with provisions that made them unenforceable. Instead, agricultural cooperatives received uncultivated land from a special provincial commission, composed of the president of the Court of Appeals, one representative of the agrarians and one representative of the peasants.
Alongside promotions of general law enforcement and upgrades to courts, the package also provided funding for strengthening the PET's activities in the North Atlantic, and provided new maritime equipment to Greenlandic and Faroese police in response to the crisis. By 19 January 2026, a total of over kr. 88 billion (US$13.7 billion) had been committed to "strengthen defense and security in the Arctic", with kr. 29 billion allocated to acquiring F-35 fighter jets alone, and kr. 27.8 billion for anti-aircraft warfare, according to the Ministry of Defence, and at that point Denmark had sent 200 additional soldiers to Greenland. On the same day, more soldiers together with the Chief of the Royal Danish Army, General Peter Harling Boysen, started arriving in Greenland, and Denmark announced that a "substantial contribution" of its armed forces would be sent there. Also on 19 January, Defence Minister Troels Lund Poulsen and Greenlandic Minister of Foreign Affairs Vivian Motzfeldt met NATO secretary general Rutte and their Nordic Security ministers in Brussels about the situation in Greenland. General Boysen said he is ready to defend Greenland. According to Boysen, the soldiers landed in Kangerlussuaq in western Greenland. On 20 January 2026, Denmark deployed additional troops to Greenland, sending dozens of soldiers and senior military leadership to the Arctic territory to reinforce its presence and participate in ongoing multinational exercises, increasing the Danish Armed Forces' personnel stationed there amid heightened international tensions.
==== Interactions with B cells ==== Macrophages have been shown to secrete cytokines BAFF and APRIL, which are important for plasma cell isotype switching. APRIL and IL-6 secreted by macrophage precursors in the bone marrow help maintain survival of plasma cells homed to the bone marrow.
Chylomicron retention disease is a disorder of fat absorption. It is associated with SAR1B. Mutations in SAR1B prevent the release of chylomicrons in the circulation which leads to nutritional and developmental problems. It is a rare autosomal recessive disorder with around 40 cases reported worldwide. Since the disease allele is recessive, parents usually do not show symptoms. Without functional chylomicrons, certain fat-soluble vitamins such as vitamin D and vitamin E cannot be absorbed. Chylomicrons have a crucial role in fat absorption and transport, thus a deficiency in chylomicron functioning reduces available levels of dietary fats and fat-soluble vitamins.
The two substrates of this enzyme are ethyl (R)-3-hydroxyhexanoate and oxidised nicotinamide adenine dinucleotide phosphate (NADP+). Its products are ethyl 3-oxohexanoate, reduced NADPH, and a proton. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is ethyl-(R)-3-hydroxyhexanoate:NADP+ 3-oxidoreductase. This enzyme is also called 3-oxo ester (R)-reductase.
Sources: en.wikipedia.org
== Public perception == The nature of the product and the manner in which it is processed led to concerns that it might be a risk to human health. There have been no reported cases of foodborne illnesses due to consumption of the product. Among consumers, media reporting significantly reduced its acceptance as an additive to ground beef. A Harris Interactive survey commissioned by Red Robin and released on April 4, 2012, found that 88% of US adults were aware of the "pink slime" issue, and that of those who were aware, 76% indicated that they were "at least somewhat concerned", with 30% "extremely concerned". 53% of respondents who stated that they were aware of pink slime took some action, such as researching ground beef they purchase or consume, or decreasing or eliminating ground beef consumption.
== Causes == The etiology, or causes, of BPD involves several causes, with no consensus on a single one. BPD may share a connection with post-traumatic stress disorder (PTSD), with both having a traumatic substrate. While childhood trauma is a recognized contributing factor, the roles of congenital brain abnormalities, genetics, neurobiology, and non-traumatic environmental factors remain subjects of ongoing investigation.
Because of these persecutions, the trade agreements with New Spain he had been trying to establish were also denied. In the end, his efforts seem to have had few results, and he died two years later of illness. The ship ended up in the ownership of Diego Sarmiento de Acuña, 1st Count of Gondomar.
To create a T2-weighted image, magnetization is allowed to decay before measuring the MR signal by changing the echo time (TE). This image weighting is useful for detecting edema and inflammation, revealing white matter lesions, and assessing zonal anatomy in the prostate and uterus. The information from MRI scans comes in the form of image contrasts based on differences in the rate of relaxation of nuclear spins following their perturbation by an oscillating magnetic field (in the form of radiofrequency pulses through the sample). The relaxation rates are a measure of the time it takes for a signal to decay back to an equilibrium state from either the longitudinal or transverse plane. Magnetization builds up along the z-axis in the presence of a magnetic field, B0, such that the magnetic dipoles in the sample will, on average, align with the z-axis summing to a total magnetization Mz. This magnetization along z is defined as the equilibrium magnetization; magnetization is defined as the sum of all magnetic dipoles in a sample. Following the equilibrium magnetization, a 90° radiofrequency (RF) pulse flips the direction of the magnetization vector in the xy-plane, and is then switched off. The initial magnetic field B0, however, is still applied. Thus, the spin magnetization vector will slowly return from the xy-plane back to the equilibrium state. The time it takes for the magnetization vector to return to its equilibrium value, Mz, is referred to as the longitudinal relaxation time, T1.
Bonded leather, also called reconstituted leather, composition leather or blended leather, is a term used for a manufactured upholstery material which contains animal hide. It is made as a layered structure of a fiber or paper backer covered with a layer of shredded leather fibers mixed with natural rubber or a polyurethane binder that is embossed with a leather-like texture. It differs from bicast leather, which is made from solid leather pieces, usually from the split, which are given an artificial coating. Bonded leather may be made in a similar manner using casting paper.
Sources: en.wikipedia.org
It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.
It binds REV-ERBα and REV-ERBβ and changes transcription of metabolic genes. This can affect circadian rhythm, lipid use, and mitochondrial function. The full downstream effects are still under study.
No. Some rodent studies show increased endurance, but controlled human trials are lacking. Claims about human performance are not established by published evidence.
Liquid chromatography-tandem mass spectrometry is a common approach. It can detect the parent compound and its metabolites in biological matrices.